Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 4/20 | 1.00 |
| ▸ | NR4A2 | P43354 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.72 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.72 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.64 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.64 |
| ▸ | PTGIR | P43119 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.64 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prostaglandin A1 SCHEMBL6417551 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL11650631 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL17914205 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL8347686 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL14577651 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL23717317 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL6417548 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL13649323 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL22425783 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL8347690 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174476-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PROSTAGLANDINS AND RELATED COMPOUNDS | TECHFIELDS PHARMA CO., LTD. (CN) | 2023-06-08 | — | — | US | disclosed |
| US-20200038352-A1 | CO-CRYSTALS OF NURR1-LBD IN COMPLEX WITH A CYCLOPENTENONE PROSTAGLANDIN AND MODULATORS OF NURR1 | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-02-06 | — | — | US | disclosed |
| EP-3195857-A1 | USE OF A TRP MODULATOR FOR THE PROPHYLAXIS AND/OR ALLEVIATING OF GRASS TETANY AND/OR PARTURIENT PARESIS IN TYLOPODA OR RUMINANTS | Freie Universität Berlin (DE) | 2017-07-26 | — | — | EP | disclosed |
| US-9693971-B2 | Compositions for alleviating gastrointestinal tract disorders or associated systemic disorders in ruminants and camelids | FREIE UNIVERSITÄT BERLIN (DE) | 2017-07-04 | — | — | US | disclosed |
| EP-2879662-B1 | COMPOSITION FOR ALLEVIATING GASTROINTESTINAL DEFECTS OR SYSTEMIC SYMPTOMES ASSOCIATED HEREWITH IN RUMINANTS AND CAMELIDS | FREIE UNIVERSITÄT BERLIN (DE) | 2017-02-08 | — | — | EP | disclosed |
| US-20150164822-A1 | COMPOSITIONS FOR ALLEVIATING GASTROINTESTINAL TRACT DISORDERS OR ASSOCIATED SYSTEMIC DISORDERS IN RUMINANTS AND CAMELIDS | PERFORMANAT GMBH (DE) | 2015-06-18 | — | — | US | disclosed |
| EP-2879662-A1 | COMPOSITIONS FOR ALLEVIATING GASTROINTESTINAL TRACT DISORDERS OR ASSOCIATED SYSTEMIC DISORDERS IN RUMINANTS AND CAMELIDS | Freie Universität Berlin (DE) | 2015-06-10 | — | — | EP | disclosed |
| US-8722739-B2 | Amino acid salts of prostaglandins | NOVAER HOLDINGS, INC. (US) | 2014-05-13 | — | — | US | disclosed |
| WO-2014020067-A1 | COMPOSITIONS FOR ALLEVIATING GASTROINTESTINAL TRACT DISORDERS OR ASSOCIATED SYSTEMIC DISORDERS IN RUMINANTS AND CAMELIDS | FREIE UNIVERSITÄT BERLIN (DE) | 2014-02-06 | — | — | WO | disclosed |
| US-20140031423-A1 | AMINO ACID SALTS OF PROSTAGLANDINS | NOVAER HOLDINGS, INC. (US) | 2014-01-30 | — | — | US | disclosed |
| US-8623918-B2 | Amino acid salts of prostaglandins | NOVAER HOLDINGS, INC. (US) | 2014-01-07 | — | — | US | disclosed |
| US-8470882-B2 | — | — | 2013-06-25 | — | — | US | disclosed |
| US-20100105771-A1 | AMINO ACID SALTS OF PROSTAGLANDINS | NOVAER HOLDINGS, INC. | 2010-04-29 | — | — | US | disclosed |
| US-20100105775-A1 | AMINO ACID SALTS OF PROSTAGLANDINS | NOVAER HOLDINGS, INC. | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174476-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PROSTAGLANDINS AND RELATED COMPOUNDS | HPGDS, PTGER1, PTGIS | TRPA1 944/4885NR4A2 1828/4885MEN1 3170/4885 |
| US-20100105771-A1 | AMINO ACID SALTS OF PROSTAGLANDINS | PTGIS, PTGES, PTGIR | TRPA1 1223/4885NR4A2 4579/4885MEN1 3153/4885 |
| US-20100105775-A1 | AMINO ACID SALTS OF PROSTAGLANDINS | PTGIS, PTGES, PTGIR | TRPA1 1223/4885NR4A2 4579/4885MEN1 3153/4885 |
| US-20140031423-A1 | AMINO ACID SALTS OF PROSTAGLANDINS | PTGIS, PTGES, PTGIR | TRPA1 1223/4885NR4A2 4579/4885MEN1 3153/4885 |
| US-20200038352-A1 | CO-CRYSTALS OF NURR1-LBD IN COMPLEX WITH A CYCLOPENTENONE PROSTAGLANDIN AND MODULATORS OF NURR1 | NCOR1, NCOA1, NR0B1 | TRPA1 2781/4885NR4A2 13/4885MEN1 4811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.